Ingevity Corp buy BMO Capital Markets
Start price
10.12.25
/
50%
€46.50
Target price
10.12.26
€60.10
Performance (%)
21.72%
Price
03.02.26
€56.40
Summary
This prediction is currently active. The BUY prediction by BMO_Capital_Markets currently has a performance of 21.72%. This prediction currently runs until 10.12.26. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ingevity Corp | 1.348% | 1.348% |
| iShares Core DAX® | -0.559% | 0.738% |
| iShares Nasdaq 100 | -0.566% | -0.324% |
| iShares Nikkei 225® | 1.073% | 5.624% |
| iShares S&P 500 | 0.868% | 0.030% |
Comments by BMO_Capital_Markets for this prediction
In the thread Ingevity Corp diskutieren
Ingevity (NYSE:NGVT) had its price target raised by analysts at BMO Capital Markets from $64.00 to $70.00. They now have an "outperform" rating on the stock.
Ratings data for NGVT provided by MarketBeat